MeaganAnneJacobyMD

Oncology • Saint Louis, MO

Hematologic Oncology

Instructor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Dr. Jacoby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jacoby's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-454-8304

Fax+1 314-454-5902

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2011
Washington University in St. Louis School of MedicineResidency, 2005 - 2007
Washington University in St. Louis School of MedicineClass of 2005

Certifications & Licensure

MO State Medical License 2011 - 2026
American Board of Internal Medicine Medical Oncology

Clinical Trials

Aging, Geriatric Syndromes and Clonal Hematopoiesis Start of enrollment: 2016 Mar 10
Recruiting
Roles: Principal Investigator, Contact
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS Start of enrollment: 2022 Jul 27
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS Start of enrollment: 2021 Sep 17
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration Start of enrollment: 2020 Jan 29
Recruiting
Roles: Contact, Principal Investigator
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2022 May 12
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance Start of enrollment: 2016 Jul 06
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
Bahareh A Mojarad, Zachary D Crees, Molly C Schroeder, Zhifu Xiang, Justin Vader
Cancer Genetics. 2024-01-01
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation.
Ziheng Xu, Jaebok Choi, Matthew Cooper, Jeffrey King, Mark A Fiala
Transplantation and Cellular Therapy. 2023-11-01
3 citations
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia.
Amber Afzal, Mark A Fiala, Meagan A Jacoby, Matthew J Walter
Blood Advances. 2023-08-08